Study Evaluating Mitoxantrone in Multiple Sclerosis
Clinical trial NCT00146159 · TERMINATED
Trial details
- NCT number
- NCT00146159
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2007-09-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.